Correlation of adenomyosis features to live birth rates after the first IVF/ICSI treatment, when using the revised Morphological Uterus Sonographic Assessment group definitions

Sara Alson,Emir Henic,Stefan R. Hansson,Povilas Sladkevicius
DOI: https://doi.org/10.1111/aogs.14986
2024-10-11
Acta Obstetricia Et Gynecologica Scandinavica
Abstract:Women with direct or indirect Morphological Uterus Sonographic Assessment (MUSA) group features of adenomyosis had lower live birth rates after IVF/ICSI treatment compared to women without. Introduction Data regarding the impact of adenomyosis on the outcomes after in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) treatment are conflicting. Standardized diagnostic criteria are prerequisites for studying a potential association between adenomyosis and IVF/ICSI treatment outcomes. This study aims to examine the cumulative live birth rate (CLBR) after the first IVF/ICSI treatment in women with or without direct or indirect features of adenomyosis, using the revised Morphological Uterus Sonographic Assessment (MUSA) group definitions. Material and Methods This was a prospective cohort study of 1037 women aged 25–≤39 years, undergoing their first IVF/ICSI treatment between January 2019 and October 2022. The presence of MUSA features of adenomyosis was assessed prior to treatment start. Results The CLBR after the first IVF/ICSI treatment was 424/1037 (40.9%, 95% CI, 37.9–43.8) in the total cohort. Women with direct features of adenomyosis had lower CLBR, 25/102 (24.5%; 95% CI, 17.5–31.5) than women without, 399/935 (42.7%; 95% CI, 39.5–45.8), p
obstetrics & gynecology
What problem does this paper attempt to address?